Prostate cancer

Radiation oncology

GU session

ADT timing

Neoadjuvant vs concurrent ADT

Intermediate-risk prostate cancer

High-risk prostate cancer

Decipher genomic classifier

Artera AI

Molecular biomarkers in radiation

PSMA PET imaging

Brachytherapy vs IMRT

SBRT (Stereotactic Body Radiation Therapy)

RTOG 0815 trial

ASCENDE-RT trial

PACE B trial

Hormone therapy duration

Pelvic radiation debate

TURP and radiation toxicity

Gleason score variability

Castrate-resistant prostate cancer

Oligometastatic prostate cancer

Pluvicto therapy

SIB (Simultaneous Integrated Boost)

Radiation dose escalation

Quality of life after ADT

Phoenix definition for PSA recurrence

Radiation toxicity and prostate volume

General Topics:

Evidence-based radiation therapy planning

Personalized treatment strategies in prostate cancer

Use of genomic and imaging tools to stratify risk

Clinical decision-making in borderline or discordant cases

Limitations and gaps in existing trial data
Real-world applications of trial results